Mushroom antioxidant eases period pain in small trial

An antioxidant called L-ergothioneine, found in certain mushrooms, reduced period pain in a small study of 40 women. Participants took a daily 120-milligram supplement over three menstrual cycles, reporting lower pain scores compared to a placebo group. The findings suggest it targets oxidative stress in uterine cells.

Researchers led by Guohua Xiao at Gene III Biotechnology Co. in Nanjing, China, tested L-ergothioneine on women aged 18 to 30 with primary dysmenorrhea, a common cause of menstrual pain not linked to conditions like endometriosis. None had used painkillers or other treatments in the prior month. Half received 120 milligrams of the supplement daily for three cycles; the rest got a placebo. Initial pain scores averaged 4.8 out of 10, dropping to 4.1, 3.6 and 2.3 for the supplement group, with no notable change in the placebo group, according to a preprint on medRxiv (DOI: 10.64898/2026.03.26.26349375). No side effects were reported in either group. Xiao explained that L-ergothioneine accumulates in cells over time, potentially neutralizing free radicals in uterine tissue before inflammation escalates. “Instead of treating the symptom acutely when the pain is already severe, EGT acts as a nutritional foundational support, potentially reducing the reliance on strong medications,” Xiao said. The study found no difference in systemic inflammation levels between groups, supporting a localized antioxidant effect, Xiao added. Andrea Maier at the University of Melbourne called the mechanism biologically plausible but urged a larger trial for confirmation. Xiao's team plans a multi-center study to assess safety and efficacy further. Long-term painkiller use like ibuprofen carries risks including heart issues and kidney problems, unlike this supplement, which the kidneys excrete once saturated.

Articoli correlati

Scientific illustration depicting parathyroid hormone strengthening mouse vertebral endplates to repel pain nerves, reducing chronic low back pain in spinal degeneration models.
Immagine generata dall'IA

Study links parathyroid hormone to reduced chronic low back pain in mice by limiting abnormal nerve growth

Riportato dall'IA Immagine generata dall'IA Verificato

A study published in the journal *Bone Research* reports that parathyroid hormone (PTH) reduced pain-related behaviors in mouse models of spinal degeneration, apparently by strengthening vertebral endplates and triggering bone-cell signals that repel pain-sensing nerve fibers. The work was led by Dr. Janet L. Crane of Johns Hopkins University School of Medicine.

Researchers at University College London have discovered how the body naturally shuts down inflammation using fat-derived molecules called epoxy-oxylipins. These molecules prevent the buildup of immune cells linked to chronic diseases like arthritis and heart disease. A study involving a drug that boosts these molecules showed faster pain relief and reduced harmful immune activity.

Riportato dall'IA

Researchers at Tokyo University of Science have discovered that combining common plant compounds from mint, eucalyptus, and chili peppers dramatically enhances their anti-inflammatory effects in immune cells. Certain pairings amplified the response several hundred-fold compared to individual use. The findings, published in the journal Nutrients, suggest potential for new dietary approaches to combat chronic inflammation.

Researchers have found that psilocybin, the hallucinogenic compound in magic mushrooms, likely evolved as a defense mechanism against insects that feed on fungi. Experiments with fruit fly larvae showed reduced survival and impaired development when exposed to the substance. This discovery sheds light on the evolutionary purpose of psychedelics in nature.

Riportato dall'IA

Scientists have developed a compound called Mic-628 that advances the body's internal clock, potentially easing jet lag. In tests on mice, a single dose reduced adjustment time to a shifted schedule from seven days to four. The discovery targets a key protein to synchronize rhythms across the body.

Researchers at ETH Zurich report that hypoxia-inducible factor 1 (HIF1) can actively drive harmful tendon changes linked to conditions such as Achilles tendon pain and tennis elbow. In mouse models and in human tendon cells collected during surgery, elevated HIF1 was associated with pathological remodeling that made tendon tissue more brittle and was accompanied by neurovascular ingrowth that may help explain pain.

Riportato dall'IA Verificato

Researchers in Brazil report that prolonged use of the proton pump inhibitor (PPI) omeprazole altered iron and calcium measures in adult rats and shifted how several minerals were distributed across organs—changes they say are consistent with higher risks of anemia and possible bone health harms. The authors and Brazil’s health regulator stress that PPIs remain effective for acid-related disorders, but warn against extended, unsupervised use.

Questo sito web utilizza i cookie

Utilizziamo i cookie per l'analisi per migliorare il nostro sito. Leggi la nostra politica sulla privacy per ulteriori informazioni.
Rifiuta